Rochester, NY 8/24/2009 9:32:37 AM
Cell Therapeutics, Inc. CTIC , 30,236,058 on heavy volume
Cell Therapeutics, Inc.
Cell Therapeutics, Inc. CTIC, surges 4.9 percent today on over 1.3 billion shares.
Last Trade: 1.69
Trade Time: Aug 21
Change: Up 0.04 (2.42%) Prev Close: 1.10
Open: 1.70
Bid: 0.79 x 200
Ask: N/A
1y Target Est: 50.00
Day's Range: 1.66 - 1.72
52wk Range: 0.05 - 2.70
Volume: 30,236,058
Avg Vol (3m): 25,260,800
Market Cap: 914.57M
P/E (ttm): N/A
EPS (ttm): -19.28
Div & Yield: N/A (N/A)
Cell Therapeutics, Inc., a biopharmaceutical company, develops, acquires, and commercializes oncology products for cancer treatment. Its development portfolio includes Pixantrone, a phase III trial product, for non-Hodgkins lymphoma; Brostallicin, which is in first-line Phase II study for the treatment of sarcoma; and OPAXIO, a chemotherapeutic agent for the potential treatment of non-small cell lung, ovarian, and other cancers. It has collaboration and licensing arrangements with Novartis International Pharmaceutical, Ltd.; and PG-TXL Company, L.P.
About WhisperFromWallStreet
WhisperFromWallStreet.com has a dedicated team uncovering stocks ready to break and run. We apply time tested criteria and when one of these stocks meets or exceeds our benchmarks, our subscribers are immediately notified.
This is a free service available only to subscribers. Scroll to the bottom of this page to signup for free stock alerts and visit our site.
Disclaimer: Full disclaimer at http://WhisperFromWallStreet.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither WhisperfromWallStreet, nor any of its affiliates are registered investment advisors or broker dealers.
